menu
    • menu

    Company profile for Evogene

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Evogene (NASDAQ:EVGN, TASE: EVGN.TA) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artifi...
    Evogene (NASDAQ:EVGN, TASE: EVGN.TA) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EvogeneIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    13 Gad Feinstein st., Park Rehovot, Rehovot
    Telephone
    Telephone
    972-8-9311900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.evogene.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Evogene Reports Receipt Of Nasdaq Minimum Bid Price Notification
    Evogene Reports Receipt Of Nasdaq Minimum Bid Price Notification

    02 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evogene-reports-receipt-of-nasdaq-minimum-bid-price-notification-302732572.html

    PR NEWSWIRE
    02 Apr 2026
    Share Share
    Evogene Showcases Pharma Discoveries At Bio-Europe Spring 2026
    Evogene Showcases Pharma Discoveries At Bio-Europe Spring 2026

    09 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evogene-to-present-its-pharma-discovery-achievements-at-bio-europe-spring-2026-302708080.html

    PR NEWSWIRE
    09 Mar 2026
    Share Share
    Evogene Releases CEO Letter To Shareholders
    Evogene Releases CEO Letter To Shareholders

    25 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evogene-releases-ceo-letter-to-shareholders-302696920.html

    PR NEWSWIRE
    25 Feb 2026
    Share Share
    Evogene Plans 2025 Q4 And Full Year Financial Results Release
    Evogene Plans 2025 Q4 And Full Year Financial Results Release

    19 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evogene-schedules-fourth-quarter-and-full-year-2025-financial-results-release-302692436.html

    PR NEWSWIRE
    19 Feb 2026
    Share Share
    Evogene And (QUT) Partner To Advance AI Cancer Therapeutics
    Evogene And (QUT) Partner To Advance AI Cancer Therapeutics

    17 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evogene-and-queensland-university-of-technology-qut-announce-a-collaboration-to-advance-ai-driven-cancer-therapeutics-302689404.html

    PR NEWSWIRE
    17 Feb 2026
    Share Share
    Evogene, Systasy & LMU Munich Partner on Neutrophil Research
    Evogene, Systasy & LMU Munich Partner on Neutrophil Research

    11 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evogene-systasy-and-lmu-university-hospital-munich-announce-a-collaboration-to-develop-novel-therapies-for-neutrophil-derived-inflammatory-diseases-302685020.html

    PR NEWSWIRE
    11 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search